William E. Evans

Genetics · 2002–2018

A researcher in the Science corpus: 15 papers; trusts 4 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Genetics — 51 citations into it; #2,535 of 6,854 by trust here, #2,063 by citations
• Pharmacology — 27 citations into it; #258 of 1,112 by trust here, #267 by citations
• Oncology — 25 citations into it

Whom William E. Evans trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Richard M. Weinshilboum
2. Howard L. McLeod
3. Magnus Ingelman-Sundberg

Who trusts William E. Evans overall

1. M. Eichelbaum
2. Magnus Ingelman-Sundberg
3. Ching-Hon Pui
4. Douglas B. Kell
5. David Broadhurst
6. Shan Zhao
7. Mary V. Relling
8. Richard M. Weinshilboum

Papers from William E. Evans's perspective

Ordered by how strongly the researchers William E. Evans trusts endorse each paper. Same corpus, a different order for every researcher.

1. Analysis of protein-coding genetic variation in 60,706 humans
2. Molecular classification of human carcinomas by use of gene expression signatures. (Cancer Research)
3. Genetic Structure of Human Populations
4. Multiclass cancer diagnosis using tumor gene expression signatures (Proceedings of the National Academy of Sciences of the United States of America)
5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (Nature)
6. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. (Blood)
7. Inheritance and drug response. (New England Journal of Medicine)
8. Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia (Nature Genetics)
9. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia (New England Journal of Medicine)
10. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (Nature)

Their papers

• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia (2007) — 1,888 citations
• Moving towards individualized medicine with pharmacogenomics (2004) — 776 citations
• Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing (2018) — 402 citations
• Pharmacogenomics in the clinic (2015) — 790 citations
• Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. (2015) — 870 citations
• Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (2014) — 1,229 citations
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia (2012) — 712 citations
• The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (2012) — 1,571 citations
• A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study (2009) — 911 citations
• Treating childhood acute lymphoblastic leukemia without cranial irradiation. (2009) — 1,165 citations
• Pharmacogenomics and individualized drug therapy. (2006) — 673 citations
• Treatment of acute lymphoblastic leukemia. (2006) — 996 citations
• Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. (2004) — 623 citations
• Pharmacogenomics--drug disposition, drug targets, and side effects. (2003) — 1,734 citations
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. (2002) — 1,999 citations